Antoine Grandperrin

Antoine Grandperrin

Auto-generated profile, based on publicly available information

Antoine Grandperrin

Avignon Université, LaPEC, UPR4278, Avignon, F-84000, France

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
LBLauréline Boutonnet
Lauréline Boutonnet
JMJoris Mallard
Joris Mallard
ACAnne-Laure Charles
Anne-Laure Charles
EHElyse Hucteau
Elyse Hucteau
BGBernard Gény
Bernard Gény
AGAntoine Grandperrin
Antoine Grandperrin
Ischemia-reperfusion injury leads to severe muscular damage. Even if prompt revascularization is the treatment of choice, muscular alterations can lead to severe sequalae as mitochondrial dysfunction. Accordingly, adjunctive strategies are needed to overcome the muscular damage. Mitochondrial transplantation has shown beneficial effects in cardiac ischemia-reperfusion, but its role in peripheral muscle is not well established. In this study, we found that mitochondrial transplantation partially restored muscular function when submitted to ischemia reperfusion.

12 August 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
MJMatthieu Josse
Matthieu Josse
CTCécile Turc-Baron
Cécile Turc-Baron
LPLaure Patrier
Laure Patrier
Philippe ConnesPhilippe Connes
Philippe Connes
AGAntoine Grandperrin
Antoine Grandperrin
POPhilippe Obert
Philippe Obert
Key Points: Physical exercise before hemodialysis is as cardioprotective as intradialytic exercise. Predialytic exercise potentially addresses several modality-specific barriers and challenges encountered by both health care providers and patients. These are likely mediated by mechanisms inherent to exercise itself, rather than by transient central and/or systemic hemodynamic alterations. Background: Hemodialysis induces left ventricular regional wall motion abnormalities (RWMAs) due to myocardial hypoperfusion. Although acute intradialytic exercise (IDE) has shown cardioprotective effects, its routine implementation faces feasibility challenges, and the potential of predialysis exercise as an alternative remains unexplored. This study aimed to compare the effect of predialysis exercise and IDE on hemodialysis-induced myocardial stunning. Methods: In this open-label, randomized cross-over trial, 25 patients with ESKD underwent to each of three hemodialysis conditions, administrated in random order: standard hemodialysis (HD-CONT), hemodialysis with IDE (HD-PER), and hemodialysis preceded by exercise (HD-PRE). Two-dimensional echocardiography and whole blood viscosity (WBV) measurements were performed both immediately before hemodialysis onset (T0) and at peak stress of hemodialysis (Tpeak). Left ventricular longitudinal strain from an 18-segment model was used to assess the presence of RWMAs. Regular monitoring of cardiovascular hemodynamics was set up with measurements staggered every 30 minutes. Results: Compared with HD-CONT, there was a significant reduction in RWMAs during both HD-PER (estimated difference, 1.60 segments; 95% confidence interval, 0.09 to 3.10; P = 0.04) and HD-PRE (estimated difference, 1.72 segments; 95% confidence interval, 0.21 to 3.22; P = 0.02). The magnitude of the exercise-induced reduction in myocardial stunning did not differ between HD-PER and HD-PRE (P = 0.86). Apart from the exercise period itself, kinetics of all hemodynamic variables were similar between HD-CONT and HD-PER, whereas they were totally similar between HD-CONT and HD-PRE. No associations of changes in RWMAs and hemodynamics variables between HD-CONT versus HD-PRE or HD-PER were found (P > 0.42). Comparing HD-CONT versus HD-PER, WBV was preserved in HD-PER and changes in RWMAs were associated with changes in WBV at high shear rates (225 s−1: P = 0.006; 90 s−1: P = 0.04). Conclusions: Physical exercise performed before hemodialysis provides cardioprotective effects comparable with those of IDE. The mechanisms behind these benefits do not seem to involve hemodynamic factors. Clinical Trial registry name and registration number: NCT04831021.

1 January 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
AGAntoine Grandperrin
Antoine Grandperrin
MBMathilde Bourgoin
Mathilde Bourgoin
SGSandrine Gayrard
Sandrine Gayrard
DBDoria Boulghobra
Doria Boulghobra
GWGuillaume Walther
Guillaume Walther
GMGregory Meyer
Gregory Meyer
Hyperglycemia (HG) is associated with increased mortality and morbidity in acute ischemic events. Regardless of the tissue or organs involved, the vascular endothelium is a key target of ischemia-reperfusion (I/R) injury severity. Among endothelium-protective strategies, exercise has been widely described as useful. However, whether this strategy is able to impact the deleterious effect of HG on endothelial function during I/R has never been challenged. For this, 48 male Wistar rats were randomized into 4 groups: sedentary (Sed) or exercised (Ex, 45 min/day, 5 days/week for 5 weeks) rats, treated (hyperglycemic, HG) or not (normoglycemic, NG) with streptozotocin (40 mg/kg, 48 h before procedure). Vascular I/R (120/15 min) was performed by clamping the femoral artery. Arterial and downstream muscular perfusions were assessed using laser speckle contrast imaging. Vascular endothelial function was assessed in vivo 15 min after reperfusion. HG was responsible for impairment of reperfusion blood flow as well as endothelial function. Interestingly exercise was able to prevent those impairments in the HG group. In agreement with the previous results, HG increased reactive oxygen species production and decreased nitric oxide bioavailability whereas exercise training normalized these parameters. It, therefore, appears that exercise may be an effective prevention strategy against the exacerbation of vascular and muscular damage by hyperglycemia during I/R.

23 September 2026 in Redox Biology
Verified
Journal Article
Open access
MGMaxime Gouin-Gravezat
Maxime Gouin-Gravezat
DBDoria Boulghobra
Doria Boulghobra
AGAntoine Grandperrin
Antoine Grandperrin
BABeatrice Alpha-Bazin
Beatrice Alpha-Bazin
OCOlivier Cazorla
Olivier Cazorla
CRCyril Reboul
Cyril Reboul
Protein S-nitrosylation (SNO), a reversible nitric oxide (NO)-dependent post-translational modification to reactive cysteine residues, finely tunes cardiac excitation-contraction coupling, mitochondrial function, and stress responses. In cardiomyocytes, compartmentalized NO signaling via neuronal (nNOS), endothelial (eNOS), and inducible (iNOS) isoforms regulates SNO of key proteins (e.g., RyR2, LTCC, SERCA2a, mitochondrial Complex I). Under physiological conditions, SNO modulates Ca2+ handling, myofilament sensitivity, and bioenergetics, while pathological SNO dysregulation, hypo-nitrosylation in heart failure (HF) with reduced ejection fraction or hypernitrosylation in HF with preserved ejection fraction, contributes to contractile dysfunction, arrhythmias, and mitochondrial impairment. Cardioprotective SNO (e.g., during ischemia-reperfusion) acts as a "redox shield", preventing irreversible oxidation of critical cysteines, whereas excessive or mislocalized SNO can be detrimental, this dynamic modification plays an essential role in maintaining cardiac function. However, disruption of NO bioavailability and redox balance during cardiovascular disease alters the cardiac S-nitrosoproteome, contributing to maladaptive signaling, mitochondrial dysfunction, contractile impairment, and pathological remodeling. Increasing evidence also highlights the dual nature of SNO exerts either protective or detrimental effects depending on the molecular context, subcellular localization, and disease stage. This review summarizes current knowledge on SNO mechanisms in the heart and discusses its roles in physiological cardiac function and major cardiac pathologies.